MindMaze Therapeutics Holding SA Share Price
Stocks
RLF
CH1251125998
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
16:30:23 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1934 CHF | +7.09% |
|
+1.79% | -89.82% |
| 08-27 | MindMaze Therapeutics' H1 Net Loss Widens; Total Revenue Rises | MT |
| 08-10 | MindMaze Therapeutics Streamlines Organization via Series of Transactions | MT |
| Market Cap | 27.56M 34.11M 29.39M 25.16M 47.39M 3.26B 47.54M 327M 128M 1.65B 128M 125M 5.46B | P/E 2026 * |
-4.52x | P/E 2027 * | 1.29x |
|---|---|---|---|---|---|
| Enterprise Value | 19.14M 23.69M 20.41M 17.47M 32.92M 2.26B 33.02M 227M 88.6M 1.14B 88.95M 87.01M 3.79B | EV / Sales 2026 * |
3.24x | EV / Sales 2027 * | 0.19x |
| Free-Float |
38.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +5.76% | ||
| 1 week | +1.79% | ||
| Current month | -2.91% | ||
| 1 month | +13.76% | ||
| 3 months | -48.63% | ||
| 6 months | -72.76% | ||
| Current year | -89.82% |
| 1 week | 0.15 |  | 0.2 |
| 1 month | 0.15 | | 0.28 |
| Current year | 0.15 | | 1.87 |
| 1 year | 0.15 | | 2.92 |
| 3 years | 0.15 | | 2.92 |
| 5 years | 0.15 | | 2.92 |
| 10 years | 0.15 | | 2.92 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/25 | Sell | 140,000 | 0.0908% | |||
| 19/12/25 | Sell | 52,162 | 0.0338% | |||
| 19/12/25 | Sell | 281,968 | 0.1830% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.09% | +1.79% | - | - | 34.29M | |
| -0.78% | -1.42% | +2.49% | +22.78% | 51.14B | |
| -6.46% | -1.46% | +438.56% | +539.82% | 47.4B | |
| -0.33% | +0.34% | +38.14% | +17.55% | 43.19B | |
| -2.16% | -2.49% | +22.55% | +80.68% | 42.35B | |
| -0.31% | -1.75% | +17.23% | +52.37% | 33.23B | |
| -1.45% | -2.72% | +27.69% | +130.80% | 17.07B | |
| -1.04% | -2.37% | - | - | 16.38B | |
| -0.88% | -0.66% | +11.60% | +27.75% | 14.76B | |
| -1.20% | -1.06% | +78.94% | +46.95% | 14.15B | |
| Average | -0.86% | +0.14% | +79.65% | +114.84% | 27.97B | |
| Weighted average by Cap. | -1.86% | +1.12% | +98.19% | +136.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.9M 7.3M 6.29M 5.39M 10.15M 698M 10.18M 70M 27.31M 352M 27.42M 26.82M 1.17B | 43.2M 53.47M 46.08M 39.44M 74.29M 5.11B 74.53M 513M 200M 2.58B 201M 196M 8.55B |
| Net income | -7.81M -9.67M -8.33M -7.13M -13.43M -924M -13.48M -92.67M -36.16M -466M -36.3M -35.51M -1.55B | 24.83M 30.73M 26.48M 22.66M 42.69M 2.94B 42.83M 295M 115M 1.48B 115M 113M 4.92B |
| Net Debt | -8.42M -10.42M -8.98M -7.69M -14.48M -996M -14.52M -99.88M -38.97M -503M -39.12M -38.27M -1.67B | -19.27M -23.85M -20.55M -17.59M -33.14M -2.28B -33.24M -229M -89.2M -1.15B -89.54M -87.6M -3.82B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | CHF 0.1934 | +7.09% | 2,657,793 |
| 27/08/26 | CHF 0.1806 | +15.92% | 2,767,359 |
| 26/08/26 | CHF 0.1558 | -2.14% | 2,182,916 |
| 25/08/26 | CHF 0.1592 | -4.56% | 2,059,936 |
| 24/08/26 | CHF 0.1668 | -12.21% | 2,333,343 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RLF Stock
Select your edition
All financial news and data tailored to specific country editions
